Browse by Audience
Skip to content
Papers of the Week
The Effects of SJP-001 on Alcohol Hangover Severity: A Pilot Study.
Authors
Abstract
Despite a clear market need and many hangover products available, currently there is no hangover treatment that is supported by substantial scientific evidence demonstrating its efficacy and safety. A pilot study was conducted to investigate the effects of a potential new hangover treatment, SJP-001, and its constituents (220 mg naproxen and 60 mg fexofenadine) on hangover severity.